Literature DB >> 27753071

Inference in randomized trials with death and missingness.

Chenguang Wang1, Daniel O Scharfstein2, Elizabeth Colantuoni2, Timothy D Girard3, Ying Yan4.   

Abstract

In randomized studies involving severely ill patients, functional outcomes are often unobserved due to missed clinic visits, premature withdrawal, or death. It is well known that if these unobserved functional outcomes are not handled properly, biased treatment comparisons can be produced. In this article, we propose a procedure for comparing treatments that is based on a composite endpoint that combines information on both the functional outcome and survival. We further propose a missing data imputation scheme and sensitivity analysis strategy to handle the unobserved functional outcomes not due to death. Illustrations of the proposed method are given by analyzing data from a recent non-small cell lung cancer clinical trial and a recent trial of sedation interruption among mechanically ventilated patients.
© 2016, The International Biometric Society.

Entities:  

Keywords:  Composite endpoint; Death-truncated data; Missing data; Sensitivity analysis

Mesh:

Year:  2016        PMID: 27753071      PMCID: PMC6383567          DOI: 10.1111/biom.12594

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  11 in total

1.  Dealing with death when studying disease or physiological marker: the stochastic system approach to causality.

Authors:  Daniel Commenges
Journal:  Lifetime Data Anal       Date:  2018-11-17       Impact factor: 1.588

Review 2.  Heterogeneity in design and analysis of ICU delirium randomized trials: a systematic review.

Authors:  Elizabeth Colantuoni; Mounica Koneru; Narjes Akhlaghi; Ximin Li; Mohamed D Hashem; Victor D Dinglas; Karin J Neufeld; Michael O Harhay; Dale M Needham
Journal:  Trials       Date:  2021-05-20       Impact factor: 2.279

3.  idem: An R Package for Inferences in Clinical Trials with Death and Missingness.

Authors:  Chenguang Wang; Elizabeth Colantuoni; Andrew Leroux; Daniel O Scharfstein
Journal:  J Stat Softw       Date:  2020-05       Impact factor: 6.440

4.  Efficient Multiple Imputation for Sensitivity Analysis of Recurrent Events Data with Informative Censoring.

Authors:  Guoqing Diao; Guanghan F Liu; Donglin Zeng; Yilong Zhang; Gregory Golm; Joseph F Heyse; Joseph G Ibrahim
Journal:  Stat Biopharm Res       Date:  2020-11-05       Impact factor: 1.586

5.  Contemporary strategies to improve clinical trial design for critical care research: insights from the First Critical Care Clinical Trialists Workshop.

Authors:  Michael O Harhay; Jonathan D Casey; Marina Clement; Sean P Collins; Étienne Gayat; Michelle Ng Gong; Samir Jaber; Pierre-François Laterre; John C Marshall; Michael A Matthay; Rhonda E Monroe; Todd W Rice; Eileen Rubin; Wesley H Self; Alexandre Mebazaa
Journal:  Intensive Care Med       Date:  2020-02-18       Impact factor: 17.440

6.  Measuring and Analyzing Length of Stay in Critical Care Trials.

Authors:  Michael O Harhay; Sarah J Ratcliffe; Dylan S Small; Leah H Suttner; Michael J Crowther; Scott D Halpern
Journal:  Med Care       Date:  2019-09       Impact factor: 2.983

7.  Bayesian semi-parametric G-computation for causal inference in a cohort study with MNAR dropout and death.

Authors:  Maria Josefsson; Michael J Daniels
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2021-01-06       Impact factor: 1.864

8.  Assessing the Course of Organ Dysfunction Using Joint Longitudinal and Time-to-Event Modeling in the Vasopressin and Septic Shock Trial.

Authors:  Michael O Harhay; Alessandro Gasparini; Allan J Walkey; Gary E Weissman; Michael J Crowther; Sarah J Ratcliffe; James A Russell
Journal:  Crit Care Explor       Date:  2020-04-29

9.  Study protocol for a multicentre, prospective cohort study of the association of angiotensin II type 1 receptor blockers on outcomes of coronavirus infection.

Authors:  James A Russell; John C Marshall; Arthur Slutsky; Srinivas Murthy; Dave Sweet; Terry Lee; Joel Singer; David M Patrick; Bin Du; Zhiyong Peng; Matthew Cheng; Kevin D Burns; Michael O Harhay
Journal:  BMJ Open       Date:  2020-12-07       Impact factor: 2.692

10.  Hospital-Free Days: A Pragmatic and Patient-centered Outcome for Trials among Critically and Seriously Ill Patients.

Authors:  Catherine L Auriemma; Stephanie P Taylor; Michael O Harhay; Katherine R Courtright; Scott D Halpern
Journal:  Am J Respir Crit Care Med       Date:  2021-10-15       Impact factor: 30.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.